| Title | 14 oxylipin markers in the prognosis of ST-segment elevation myocardial infarction |
|---|---|
| Description | A fourteen oxylipin-based prognostic model that exhibited significant performance in predicting recurrent adverse clinical outcomes in patients with STEMI after PCI (PKTH center; validation cohort) during 2 years of follow up. |
| Organism | Homo sapiens |
| Data Type | Other Type of Metabolome Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA033318 |
| Release Date | 2025-03-07 |
| Submitter | Zhiyong Du (duzhiyong1989@163.com) |
| Organization | Beijing Anzhen Hospital, Capital Medical University |
| Submission Date | 2024-12-06 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX008181-01 | plasma levels of 14 oxylipin markers in STEMI patients with and without recurrent MACE | 401 | Other Type of Metabolome Data | 58.0 KB | xlsx | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|---|---|---|---|
| The prognostic and therapeutic significance of polyunsaturated fatty acid‐derived oxylipins in ST‐segment elevation myocardial infarction | iMeta | 2025-01 | OMIX008182 OMIX008181 | Deposit |